LONG-TERM OUTCOMES OF DECEASED DONOR LIVER TRANSPLANTATION

Aim of the study was to evaluate patient and graft survival after liver transplantation (LT) and to determine if primary disease diagnosis, early graft dysfunction or other factors affect it. Furthermore, we analyzed the reasons of short-term and long-term deaths or retransplantations. Materials and methods. 192 LTs from donors with brain death were performed from December 2004 until June 2014. Recipient age varied from 5 to 71 years. Most frequent diagnosis was liver cirrhosis (mainly due to hepatitis C), then hepatocellular carcinoma (HCC), liver graft dysfunction, etc. Results and discussion. 1-year patient survival is 89.5%, graft survival is 87.7%, 3-year 87% and 84.6%, respectively, and 5-year - 83.5% and 83.0%, respectively. Early mortality (in first 30 days after transplantation) was 8%, long-term mortality - 5.9%. Primary non-function graft (PNF) was the reason of 66.7% early deaths. In the long term, infections and oncology were the reasons of death with the same frequency 36.4%. Early graft dysfunction including primary non-function significantly decreases short term survival (p = 0.0002). Nevertheless, in the majority of cases graft function improves and doesn't affect survival. Donor factors play role in outcomes: early dysfunction is higher (40.6%) in extended criteria donor group than in standard donor group (p = 0.0431). PNF has the same trend - 8.5% and 0.0%, respectively, but without significance (p = 0.0835). 5-year survival is remarkably lower in HCC group 40.8% (p = 0.003) than in other groups. Conclusion: survival after liver transplantation in our Center is comparable with the results of the world's centers.